• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Studies on virulence of new gene products of cytomegalovirus

Research Project

Project/Area Number 16591078
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Embryonic/Neonatal medicine
Research InstitutionHokuriku University (2005-2006)
Kagoshima University (2004)

Principal Investigator

MURAYAMA Tsugiya  Hokuriku University, Faculty of Pharmaceutical Sciences, Professor, 薬学部, 教授 (60159184)

Co-Investigator(Kenkyū-buntansha) EIZURU Yoshito  Kagoshima University, Graduate School of Medical and Dental Sciences, Professor, 大学院医歯学総合研究科, 教授 (00041351)
Project Period (FY) 2004 – 2006
Project Status Completed (Fiscal Year 2006)
Budget Amount *help
¥2,900,000 (Direct Cost: ¥2,900,000)
Fiscal Year 2006: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 2005: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 2004: ¥1,300,000 (Direct Cost: ¥1,300,000)
KeywordsCytomegalovirus / Clinical isolated strain / UL146 / Fusion protein / 臨床分離株HCMV / BAC / 臨床分離株CMV
Research Abstract

Human cytomegalovirus (HCMV) is a herpes virus that causes disease only in immuosuppresed patients. A new open reading frames (ORF) that are frequently deleted in AD169 strain and in highly passages laboratory strains, have been identified previously. On the other hand, clinical isolates retain these ORF suggesting that the predicted gene products may be important for viral infection in vivo. Dot blot hybridization and DNA sequencing among clinical isolates of HCMV evaluated the variability of UL146 ORF that encodes for an alpha chemokine homolog. Eighteen strains (32%) out of 56 clinical isolates were positive when UL146 gene Toledo strain was used as probe for dot blot hybridization, whereas 50 strains (95%) were positive for both UL145 and UL147 probes of Toledo strain. Three strains were not reacted with any of these three probes, suggesting the absence of the genes. Only 17/56 strains (30%) were amplified using UL146 flanking primer pair and 18/56 strains (32%) were amplified using UL145 and UL147 flanking primers. The remaining 21 strains were not amplified so far. After DNA sequencing, the 35 strains were classified into 8 groups depending on UL146 DNA sequence similarity. The variability among the groups was ranged from 25.1% to 52.9% in the DNA level and from 34.5%to 67% in the amino acid level. Seven groups had interleukin-8 (IL-8) motif ERL (Glu-Leu-Arg) CXC and one group had only CXC motif, suggesting the absence of IL-8 function of UL146. In conclusion, the UL146 gene of HCMV is highly hyper variable in clinical strains in Japan and may shows different function in individuals clinical HCMV isolates.

Report

(4 results)
  • 2006 Annual Research Report   Final Research Report Summary
  • 2005 Annual Research Report
  • 2004 Annual Research Report
  • Research Products

    (11 results)

All 2007 2006 2005 2004

All Journal Article (11 results)

  • [Journal Article] Anti-cytomegalovirus activity of pristimerin, a triterpenoid quinone methide isolated from Maytenus heterophylla (Eckl. & Zehl.2007

    • Author(s)
      Tsugiya Murayama et al.
    • Journal Title

      Antiviral Chemistry & Chemotherapy 18(accepted)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Anti-cytomegalovirus activity of pristimerin, a triterpenoid quinone methide isolated from Maytenus heterophylla (Eckl. & Zehl.).2007

    • Author(s)
      Tsugiya Murayama et al.
    • Journal Title

      Antiviral Chemistry & Chemotherapy 18(accepted)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Anti-cytomegalovirus activity of pristimerin, a triterpenoid quinone methide isolated from Maytenus heterophylla (Eck1. & Zeh1.)2007

    • Author(s)
      Tsugiya Murayama et al.
    • Journal Title

      Antiviral Chemistry & Chemotherapy (accepted)

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Inhibition of ganciclovir-resistant human cytomegalovirus replication by Kampo (Japanese herbal medicine).2006

    • Author(s)
      Tsugiya Murayama et al.
    • Journal Title

      Antiviral Chemistry & Chemotherapy 17

      Pages: 11-16

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Annual Research Report 2006 Final Research Report Summary
  • [Journal Article] ヘルペスウイルス学-薬剤耐性HCMV-2006

    • Author(s)
      村山 次哉
    • Journal Title

      日本臨床 63 (3)

      Pages: 508-511

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Herpes virus-Drug resistance human cytomegalovirus.2006

    • Author(s)
      Tsugiya Murayama
    • Journal Title

      Nippon-rinsho 63(3)

      Pages: 508-511

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] ヘルペスウイルス学-薬剤耐性HCMV-2006

    • Author(s)
      村山 次哉
    • Journal Title

      日本臨床 64(3)

      Pages: 508-511

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Inhibition of ganciclovir-resistant human cytomegalovirus replication by Kampo (Japanese herbal medicine).2006

    • Author(s)
      Tsugiya Murayama et al.
    • Journal Title

      Antiviral Chemistry & Chemotherapy 17

      Pages: 11-16

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Analysis of human cytomegalovirus UL144 variability in low-passage clinical isolates in Japan.2005

    • Author(s)
      Tsugiya Murayama et al.
    • Journal Title

      Intervirology 48

      Pages: 201-206

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Analysis of human cytomegalovirus UL144 variability in low-passage clinical isolates in Japan.2005

    • Author(s)
      Tsugiya Murayama et al.
    • Journal Title

      Intervirology 48(2-3)

    • Related Report
      2004 Annual Research Report
  • [Journal Article] In vitro anti-cytomegalovirus activity of Kampo (Japanese herbal) medicine2004

    • Author(s)
      Tsugiya Murayama et al.
    • Journal Title

      eCAM (Evidence-based Complementary and Alternative Medicine) 1(3)

      Pages: 285-289

    • Related Report
      2004 Annual Research Report

URL: 

Published: 2004-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi